Literature DB >> 34097510

Adverse Events And Emergency Department Opioid Prescriptions In Adolescents.

Christopher M Worsham1, Jaemin Woo2, Anupam B Jena3, Michael L Barnett4.   

Abstract

Understanding the risks associated with opioid prescription in adolescents is critical for informing opioid policy, but the risks are challenging to quantify given the lack of randomized trial data. Using a regression discontinuity design, we exploited a discontinuous increase in opioid prescribing in the emergency department (ED) when adolescents transition from "child" to "adult" at age eighteen to estimate the effect of an ED opioid prescription on subsequent opioid-related adverse events. We found that adolescent patients just over age eighteen were similar to those just under age eighteen, but they were 9.7 percent more likely to be prescribed an opioid and 12.6 percent more likely to have an adverse opioid-related event, defined as overdose, diagnosis of opioid use disorder, or long-term opioid use, within one year. We estimated a 14.1 percent increased risk for an adverse outcome when "adults" just over age eighteen were prescribed opioids that would not have been prescribed if they were just under age eighteen and considered "children." Our results suggest that differences in care provided in pediatric versus adult care settings may be important to understanding prescribers' roles in the opioid epidemic.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34097510      PMCID: PMC8654605          DOI: 10.1377/hlthaff.2020.01762

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   9.048


  23 in total

1.  Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young Adults.

Authors:  Kao-Ping Chua; Chad M Brummett; Rena M Conti; Amy Bohnert
Journal:  JAMA Pediatr       Date:  2020-02-01       Impact factor: 16.193

2.  Associations Between Opioid Prescribing Patterns and Overdose Among Privately Insured Adolescents.

Authors:  Cornelius B Groenewald; Chuan Zhou; Tonya M Palermo; William C Van Cleve
Journal:  Pediatrics       Date:  2019-10-01       Impact factor: 7.124

3.  A new factor in youth suicide: the relative age effect.

Authors:  A H Thompson; R H Barnsley; R J Dyck
Journal:  Can J Psychiatry       Date:  1999-02       Impact factor: 4.356

4.  Attention Deficit-Hyperactivity Disorder and Month of School Enrollment.

Authors:  Timothy J Layton; Michael L Barnett; Tanner R Hicks; Anupam B Jena
Journal:  N Engl J Med       Date:  2018-11-29       Impact factor: 91.245

5.  Emergency Department Contribution to the Prescription Opioid Epidemic.

Authors:  Sarah Axeen; Seth A Seabury; Michael Menchine
Journal:  Ann Emerg Med       Date:  2018-01-16       Impact factor: 5.721

6.  Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse.

Authors:  Joseph Logan; Ying Liu; Leonard Paulozzi; Kun Zhang; Christopher Jones
Journal:  Med Care       Date:  2013-08       Impact factor: 2.983

7.  Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain: A Randomized Clinical Trial.

Authors:  Benjamin W Friedman; Andrew A Dym; Michelle Davitt; Lynne Holden; Clemencia Solorzano; David Esses; Polly E Bijur; E John Gallagher
Journal:  JAMA       Date:  2015-10-20       Impact factor: 56.272

8.  Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.

Authors:  Anh P Nguyen; Jason M Glanz; Komal J Narwaney; Ingrid A Binswanger
Journal:  JAMA Netw Open       Date:  2020-03-02

9.  Regression Discontinuity Design.

Authors:  Matthew L Maciejewski; Anirban Basu
Journal:  JAMA       Date:  2020-07-28       Impact factor: 56.272

10.  Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006-2015.

Authors:  Anuj Shah; Corey J Hayes; Bradley C Martin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-03-17       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.